Bi Asset Management Fondsmaeglerselskab A Summit Therapeutics Inc. Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $10.2 Billion
- Q2 2025
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 125,100 shares of SMMT stock, worth $2.61 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
125,100Holding current value
$2.61 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
260Shares Held
90.4MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$705 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$84 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$81.6 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.21B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...